HONG KONG, Feb. 19, 2021 /PRNewswire/ -- Global Cord Blood
Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood
collection, laboratory testing, hematopoietic stem cell processing
and stem cell storage services, today announced that it plans
to release unaudited financial results for the third quarter
and first nine months of fiscal year 2021 on Wednesday, February 24, 2021, after the U.S.
market close.
The Company will host a conference call at 8:00 a.m. ET on
Thursday, February 25, 2021 to
discuss its financial performance and give a brief overview of the
Company's recent developments, followed by a question-and-answer
session. Interested parties can access the audio webcast through
the Company's IR website at http://ir.globalcordbloodcorp.com. A
replay of the webcast will be accessible two hours after the
conference call and available for seven days at the same URL as
above. Listeners can also access the call by dialing 1-646-722-4977
or 1-855-824-5644, for U.S. callers, or +852-3027-6500, for
Hong Kong callers, access code:
28530146#.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the third quarter fiscal 2021 earnings press release
will be available at http://www.globalcordbloodcorp.com, in the
section titled "Investor Center/Press Release," after 4:16 p.m. ET
on Wednesday, February 24, 2021, and
in the Company's Report on Form 6-K for the month of
February 2021, available on the Securities and Exchange
Commission's website at www.sec.gov.
About Global Cord Blood Corporation
Global Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses. Global
Cord Blood Corporation provides cord blood collection, laboratory
testing, hematopoietic stem cell processing and stem cell storage
services. For more information, please visit the Company's website
at: http://www.globalcordbloodcorp.com.
For more information, please contact:
Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@globalcordbloodcorp.com
ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (+1) 646-405-5185
Email: william.zima@icrinc.com
View original
content:http://www.prnewswire.com/news-releases/global-cord-blood-corporation-to-report-third-quarter-and-first-nine-months-fiscal-2021-financial-results-301231477.html
SOURCE Global Cord Blood Corporation